PLA2G7 and glioblastoma: In addition to being a therapeutic target, Lp‐PLA2 has the potential to become a valuable biomarker for both predictive and prognostic applications in some cancers, such as breast cancer, glioblastoma, melanoma, and esophageal cancer.